11:00 AM EST - Labopharm Inc. : is appealing an approvable letter it received from the U.S. Food and Drug Administration on its once-daily formulation of the pain killer tramadol. The letter sets out conditions that must be met before a drug can be considered for approval, with additional analysis of its existing data. Labopharm Inc.
shares T.DDS are trading up 9 cents at $6.83.
